![Follow-up of IgD-κ multiple myeloma by monitoring free light chains and total heavy chain IgD: A case report Follow-up of IgD-κ multiple myeloma by monitoring free light chains and total heavy chain IgD: A case report](https://www.spandidos-publications.com/article_images/ol/12/3/ol-12-03-1884-g03.jpg)
Follow-up of IgD-κ multiple myeloma by monitoring free light chains and total heavy chain IgD: A case report
![Biomedicines | Free Full-Text | Serum Free Light-Chain Ratio at Diagnosis Is Associated with Early Renal Damage in Multiple Myeloma: A Case Series Real-World Study Biomedicines | Free Full-Text | Serum Free Light-Chain Ratio at Diagnosis Is Associated with Early Renal Damage in Multiple Myeloma: A Case Series Real-World Study](https://www.mdpi.com/biomedicines/biomedicines-10-01657/article_deploy/html/images/biomedicines-10-01657-g001-550.jpg)
Biomedicines | Free Full-Text | Serum Free Light-Chain Ratio at Diagnosis Is Associated with Early Renal Damage in Multiple Myeloma: A Case Series Real-World Study
![Frontiers | Case Report: A case of IgD lambda/lambda Multiple Myeloma in patient with acute renal failure and without monoclonal spike in serum electrophoresis Frontiers | Case Report: A case of IgD lambda/lambda Multiple Myeloma in patient with acute renal failure and without monoclonal spike in serum electrophoresis](https://www.frontiersin.org/files/Articles/974392/frhem-01-974392-HTML/image_m/frhem-01-974392-t001.jpg)
Frontiers | Case Report: A case of IgD lambda/lambda Multiple Myeloma in patient with acute renal failure and without monoclonal spike in serum electrophoresis
![IJMS | Free Full-Text | Next-Generation Biomarkers in Multiple Myeloma: Understanding the Molecular Basis for Potential Use in Diagnosis and Prognosis IJMS | Free Full-Text | Next-Generation Biomarkers in Multiple Myeloma: Understanding the Molecular Basis for Potential Use in Diagnosis and Prognosis](https://www.mdpi.com/ijms/ijms-22-07470/article_deploy/html/images/ijms-22-07470-g001.png)
IJMS | Free Full-Text | Next-Generation Biomarkers in Multiple Myeloma: Understanding the Molecular Basis for Potential Use in Diagnosis and Prognosis
![Figure 1 from IgD-kappa multiple myeloma. Case report and brief review of the literature | Semantic Scholar Figure 1 from IgD-kappa multiple myeloma. Case report and brief review of the literature | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f79a2c2d60e04a3f09b1e3615ba2dd6a0a0efc9f/2-Figure1-1.png)
Figure 1 from IgD-kappa multiple myeloma. Case report and brief review of the literature | Semantic Scholar
![IgE-type multiple myeloma with the late development of IgA2 kappa and plasma cell leukaemia. | Semantic Scholar IgE-type multiple myeloma with the late development of IgA2 kappa and plasma cell leukaemia. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/e49a5f8507bfe1d435c87a2f7c72dc052bb32b28/2-Figure1-1.png)
IgE-type multiple myeloma with the late development of IgA2 kappa and plasma cell leukaemia. | Semantic Scholar
![Follow-up of IgD-κ multiple myeloma by monitoring free light chains and total heavy chain IgD: A case report Follow-up of IgD-κ multiple myeloma by monitoring free light chains and total heavy chain IgD: A case report](https://www.spandidos-publications.com/article_images/ol/12/3/ol-12-03-1884-g02.jpg)